Pharma & Biotech News #PharmaBuzz

Market Place

Sourcing Support

Weekly News Recap #Phispers

Chiesi, Arbor in US$ 2 bn gene therapy deal; Lilly to invest over US$ 1 bn in India; FDA okays Boehringer's rare lung disease drug

In news this week, Italy’s Chiesi Group announced a deal worth up to US$ 2 billion with US-based Arbor Biotechnologies to...

Impressions : 3162

Trump, Pfizer seal deal to offer drug discounts; FDA approves Eli Lilly's oral breast cancer pill

This week, US President Donald Trump announced a deal with Pfizer to sell medicines through a new federal website, TrumpRx.go...

Impressions : 606

Pfizer buys Metsera for up to US$ 7.3 bn, Roche acquires 89bio; FDA okays injectable version of Merck's Keytruda

In this week’s Phispers, Pfizer announced the acquisition of New York-based biotech Metsera for up to US$ 7.3 billion, ma...

Impressions : 1270

Novartis inks US$ 5.7 bn licensing deal with Monte Rosa for immune-related diseases; GSK, Lilly pledge more investments in US

In this week’s news, drugmakers continued to invest heavily in the US in order to avoid tariffs. GSK said it will invest ...

Impressions : 935

Only few entries up to this point, click to access all

Quality Compliance Alerts #Warning!

All News #Library

Generics

Biotech

APIs

Quality

Sciences

Rare Diseases

Others

NEWS

DRUGS & DEVELOPMENTS

MARKET INTEL by PharmaCompass

Chiesi, Arbor in US$ 2 bn gene therapy deal; Lilly to invest over US$ 1 bn in India; FDA okays Boehringer's rare lung disease drug

Trump, Pfizer seal deal to offer drug discounts; FDA approves Eli Lilly's oral breast cancer pill

Pfizer buys Metsera for up to US$ 7.3 bn, Roche acquires 89bio; FDA okays injectable version of Merck's Keytruda

Novartis inks US$ 5.7 bn licensing deal with Monte Rosa for immune-related diseases; GSK, Lilly pledge more investments in US

Amneal Pharms's Generics Isotretinoin Receives Approval in US

SQ Innovation's Lasix Onyu Receives Approval In US

Boehringer Ingelheim's Jascayd Receives Approval In US

Taro's Generics Lamotrigine Receives Approval In US

Lotus's Generics Nintedanib Receives Tentative Approval In US

Annora's Generics Mirtazapine Receives Approval in US

Changzhou's Generics Doxycycline Receives Approval in US

Dr Reddys's Generics Prednisone Receives Approval in US

Annora's Generics Bupropion Hydrochloride Receives Approval in US

Eli Lilly's Inluriyo Receives Approval in US

Enforcement Report - Week of October 8, 2025

Prothya Biosolutions Netherlands B.V.'s Fails EDQM inspection

Health Canada Issues Recalls of Sandoz's Lisinopril tablet

FDA Issues Form 483 to Aurobindo Pharmaceuticals

Enforcement Report - Week of October 1, 2025.pdf

FDA Issues Form 483 to Dr. Reddy Lab

Persōn & Covey Recieves Warning Letter

Sichuan Savory Biotechnology is on FDA Import Alert List

Guangxi Yulin Pharmaceutical is on FDA Import Alert List

Produlab Pharma B.V's Fails EDQM inspection

Two Babies Evacuated From North Gaza, UNICEF Says

Senegal Reports 17 Deaths In Rift Valley Fever Outbreak

Eilean Present Pan-EGFR Inhibitor ZE77-0273 For EGFR-Mutant NSCLC

Moderna Claims Early Victory For Cancer Antigen In Melanoma

Tvardi's STAT3 Inhibitor Flunks IPF Trial Amid High Dropout Rate

Germany's LTS Boosts US Drug Delivery CDMO Footprint Through M&A

Aspen Wins Approval to Market Lilly's Mounjaro in South Africa

Roche, Lilly's Blood Test for Alzheimer's diagnosis gets approval

Companies Announce Direct-To-Consumer Sales & Price Cuts in US

FDA Adds Label Warning to J&J's and Legend Bio's Cancer Therapy

Moderna Claims Early Victory For Cancer Antigen In Melanoma

Aspen Wins Approval to Market Lilly's Mounjaro in South Africa

Tariff Pause Eases Pressure On Drug Companies

Natco Wins Patent Battle To Launch Generic 'Risdiplam'

Trump & Co Halts Generic Drug Tariffs, Boosts Indian Pharma Stock

Zydus Gets Health Canada Approval For Liothyronine Tablets

Pharmanovia Appoints Stephan Eder As CEO

Biocon Unit Gets USFDA Nod For Genetic Anti-Bacterial Drug

Gilead Inks Biktarvy Settlements With 3 Generic Drug Makers

Supreme Court Rejects Purdue's Oxycontin Patent Appeal

Tvardi's STAT3 Inhibitor Flunks IPF Trial Amid High Dropout Rate

FDA Adds Label Warning to J&J's and Legend Bio's Cancer Therapy

Zai Lab Present Updated Zocilurtatug Pelitecan Data at Confernece

ADC Therapeutics Announces $60 Million Private Placement

Thousand Oaks Biologics ADC Site receives EU QP Declaration

GC Biopharma Showcases IVIG Innovation at Fall CIIC Conference

Medicus Pharma Ltd. To Present At The Maxim Growth Summit 2025

Tenpoint Therapeutics To Join Four Investor Conferences

ONWARD Medical Updates Q3 2025: ARC-EX Adoption Accelerates In US

HMNC Brain Health Shows Genetic Tool Combo Benefit In Depression

AZ Breaks Ground On $4.5B API Production Facility In Virginia

Axway Leads 2025 Gartner API Management Magic Quadrant

Jubilant Hollisterstier Launches Sterile Fill & Finish Line

Asahi Kasei Launches Sonanos Next-Gen Excipients

HRV Pharma Unveils Brand Mascots

Piramal Pharma Solutions Implements POD Method At Aurora API

Supriya's Ambernath Facility Secures WHO GMP certification

A. P. Rameswara Rao Appointed National President Of BDMAI

US Urged To Diversify Antibiotic Imports To Cut Shortages

AbbVie Breaks Ground on Chicago API Manufacturing Plant

WHO Raises Alert Over Deg-Contaminated Cough Syrups In India

Novo Plant Issues May Mean Delays For Regeneron, Scholar Rock

Maharashtra Drug Testing Labs Ready To Detect DEG In Cough Syrups

CDSCO To Inspect Cough Syrup Manufacturing Units

EMA Allows Relying On FDA GMP Inspections Abroad

CDSCO Urges States To Ensure Raw Material Testing

India Declares Three Cough Syrups Toxic After Child Deaths

KFF Poll: US Parties Divided On Trump's Tylenol-Autism Claim

Maharashtra FDA Orders Inspection Of Liquid Oral Formulations

Xspray Hits FDA Wall With New Manufacturing-Related Rejection

Two Babies Evacuated From North Gaza, UNICEF Says

Senegal Reports 17 Deaths In Rift Valley Fever Outbreak

Roche, Lilly's Blood Test for Alzheimer's diagnosis gets approval